Related Articles Biopharma Funds Deliver Market-Beating Returns as Valuations Snap Back Stephen Taub European Managers Increasingly Turn to Active ETFs Despite Lack of Tax Benefits John Crabb 6 for 2026: Essential Questions for Investors Sponsored by BNY Investments